Author
Number of items: 70.
Article
Evaluation of emergency skin decontamination protocols in response to an acid attack (vitreolage). (2024)
Hazem Matar,
Paramesh Vuddanda
and
Robert Chilcott
Exposure to organophosphorus compounds : best practice in managing timely, effective emergency responses. (2023)
Frédéric Dorandeu,
Christopher Singer,
Steven Chatfield,
Robert P Chilcott
and
Jonathan Hall
Illicit COVID-19 products online: A mixed-method approach for identifying and preventing online health risks. (2023)
Valeria Catalani,
Honor D. Townshend,
Mariya Prilutskaya,
Robert P. Chilcott,
Antonio Metastasio,
Hani Banayoti,
Tim McSweeney
and
Ornella Corazza
Profiling the vendors of COVID‐19 related product on the Darknet: An observational study. (2023)
Valeria Catalani,
Honor D. Townshend,
Mariya Prilutskaya,
Andres Roman-Urrestarazu,
Robin van Kessel,
Robert Chilcott,
Hani Banayoti,
Tim McSweeney
and
Ornella Corazza
Quantifying the Risk to Health Care Workers of Cough as an Aerosol Generating Event in an Ambulance Setting: A Research Report. (2022)
Dale A Gedge,
Robert P Chilcott
and
Julia Williams
SARS-CoV-2: characterisation and mitigation of risks associated with aerosol generating procedures in dental practices. (2021)
Touraj Ehtezazi,
David G Evans,
Ian D Jenkinson,
Philip A Evans,
Vijay J Vadgama,
Jaimini Vadgama,
Fadi Jarad,
Nicholas Grey
and
Robert Chilcott
Decontamination and Management of Contaminated Hair following a CBRN or HazMat Incident. (2019)
Hazem Matar,
Andreia Tavares Pinhal,
Nevine Amer,
Mark Barrett,
Elliot Thomas,
Philip Hughes,
Joanne Larner
and
Robert Chilcott
Efficacy of Different Hair and Skin Decontamination Strategies with Identification of Associated Hazards to First Responders. (2019)
Joanne Larner,
Adam Durrant,
Philip Hughes,
Devanya Mahalingam,
Samantha Rivers,
Hazem Matar,
Elliot Thomas,
Mark Barrett,
Andreia Tavares Pinhal,
Nevine Amer,
Charlotte Hall,
Toni Jackson,
Valeria Catalani
and
Robert Chilcott
Evaluation of US Federal Guidelines (Primary Response Incident Scene Management [PRISM]) for Mass Decontamination of Casualties During the Initial Operational Response to a Chemical Incident. (2019)
Robert Chilcott,
Joanne Larner,
Adam Durrant,
Philip Hughes,
Devanya Mahalingam,
Samantha Rivers,
Elliot Thomas,
Nevine Amer,
Mark Barrett,
Hazem Matar,
Andreia Pinhal,
Toni Jackson,
Kate McCarthy-Barnett
and
Joseph Reppucci
Further studies of the efficacy of military, commercial and novel skin decontaminants against the chemical warfare agents sulphur mustard, soman and VX. (2019)
Hazem Matar,
Shirley Price
and
Robert Chilcott
The United Kingdom’s initial operational response and specialist operational response to CBRN and HazMat incidents: a primer on decontamination protocols for healthcare professionals. (2019)
Robert Chilcott,
Joanne Larner
and
Hazem Matar
Optimization of Nonambulant Mass Casualty Decontamination Protocols as Part of an Initial or Specialist Operational Response to Chemical Incidents. (2019)
Robert P. Chilcott,
Hannah Mitchell
and
Hazem Matar
Hybrid in vitro diffusion cell for simultaneous evaluation of hair and skin decontamination: temporal distribution of chemical contaminants. (2018)
Hazem Matar,
Nevine Amer,
Sneha Kansagra,
Andreia Pinhal,
Elliot Thomas,
Scott Townend,
Joanne Larner
and
Robert Chilcott
Sebomic identification of sex- and ethnicity-specific variations in residual skin surface components (RSSC) for bio-monitoring or forensic applications. (2018)
Satyajit Shetage,
Matthew Traynor,
Marc Brown
and
Robert Chilcott
The percutaneous absorption of soman in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant. (2018)
Christopher Dalton,
Charlotte Hall,
Helen Lydon,
John Jenner,
J Kevin Chipman,
John S Graham
and
Robert P Chilcott
Eyeing up the Future of the Pupillary Light Reflex in Neurodiagnostics. (2018)
Charlotte Hall
and
Robert Chilcott
Octodrine: New Questions and Challenges in Sport Supplements. (2018)
Valeria Catalani,
Mariya Prilutskaya,
Ahmed Al-Imam,
Shanna Marrinan,
Yasmine Elgharably,
Mire Zloh,
Giovanni Martinotti,
Robert Chilcott
and
Ornella Corazza
Application of sebomics for the analysis of residual skin surface components to detect potential biomarkers of type-1 diabetes mellitus. (2017)
Satyajit S Shetage,
Matthew J Traynor,
Marc B Brown,
Thomas M Galliford
and
Robert P Chilcott
The percutaneous toxicokinetics of sulphur mustard in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant. (2017)
Charlotte Hall,
Helen Lydon,
Christopher Dalton,
J. Kevin Chipman,
John Graham
and
Robert Chilcott
Hair analysis for the detection of drug use – is there potential for evasion? (2017)
Shanna Marrinan,
Andres Roman-Urrestarazu,
Declan Naughton,
Emerlinda Levari,
John Collins,
Robert Chilcott,
Giuseppe Bersani
and
Ornella Corazza
Volunteer trials of a novel improvised dry decontamination protocol for use during mass casualty incidents as part of the UK’S Initial Operational Response (IOR). (2017)
Richard Amlôt,
Holly Carter,
Lorna Riddle,
Joanne Larner
and
Robert P. Chilcott
Development of haemostatic decontaminants for treatment of wounds contaminated with chemical warfare agents. 3: Evaluation of in vitro topical decontamination efficacy using damaged skin. (2017)
Helen L. Lydon,
Charlotte A. Hall,
Christopher H. Dalton,
J. Kevin Chipman,
John S. Graham
and
Robert Chilcott
Captagon: Use and Trade in the Middle East. (2017)
Ahmed Al-Imam,
Rita Santacroce,
Andres Roman-Urrestarazu,
Robert Chilcott,
G. Martinotti,
Giuseppe Bersani
and
Ornella Corazza
Evaluation of absorbent materials for use as ad hoc dry decontaminants during mass casualty incidents as part of the UK’s Initial Operational Response (IOR). (2017)
Robert Chilcott,
Nick Kassouf,
Sara Syed,
Joanne Larner
and
Richard Amlôt
Mass Casualty Decontamination in the United States : An Online Survey of Current Practice. (2016)
Sarah Power,
Charles Symons,
Holly Carter,
Emma Jones,
Richard Amlôt,
Joanne Larner,
Hazem Matar
and
Robert P Chilcott
Preliminary evaluation of military, commercial and novel skin decontamination products against a chemical warfare agent simulant (methyl salicylate). (2016)
Hazem Matar,
Antonio Guerreiro,
Sergey A. Piletsky,
Shirley Price
and
Robert Chilcott
Development of a cumulative irritation model for incontinence-associated dermatitis. (2015)
J. Larner,
H. Matar,
V. S. Goldman
and
Robert Chilcott
Effect of ethnicity, gender and age on the amount and composition of residual skin surface components derived from sebum, sweat and epidermal lipids. (2014)
Satyajit Shetage,
M.J. Traynor,
Marc Brown,
Mahad Raji,
Diepiriyie Graham-Kalio
and
Robert Chilcott
Pharmacokinetics of acetylcholinesterase reactivator K203 and consequent evaluation of low molecular weight antioxidants/markers of oxidative stress. (2012)
J.Z. Karasová,
D. Hnídková,
M. Pohanka,
K. Musílek,
K. Kuča
and
Robert Chilcott
Whole-body imaging of UV-fluorescent chemical warfare simulants: A potentially quantitative technique for the optimisation of mass casualty decontamination procedures. (2009)
Joanne Larner,
Hazem Matar,
David R. Jones,
Richard Amlot,
Holly Carter,
Elizabeth A. Turner,
Shirley C. Price
and
Robert Chilcott
The in vitro efficacy of haemostatic products in the presence of chemical warfare agents-Sulphur mustard (HD) and VX. (2009)
Charlotte A. Hall,
Helen L. Lydon,
Christopher H. Dalton,
J. Kevin Chipman,
Robert Chilcott
and
John S. Graham
Decontamination of multiple casualties who are chemically contaminated : a challenge for acute hospitals. (2008)
S.F. Clarke,
Robert Chilcott,
J.C. Wilson,
R. Kamanyire,
D.J. Baker
and
A. Hallett
Managing mass casualties and decontamination. (2014)
Robert Chilcott
Ga(III) complexes-The effect of metal coordination on potential systemic absorption after topical exposure. (2011)
Kirsten Staff,
Marc Brown,
Robert Chilcott,
Robert C. Hider,
Stuart A. Jones
and
Xiao L. Kong
A preliminary study for assessing the feasibility of sebum sampling for monitoring human exposure to environmental chemicals following inadvertent or malicious release. (2008)
James C. Wakefield,
Kalwinder Kaur
and
Robert Chilcott
The skin reservoir of sulphur mustard. (2008)
I. J. Hattersley,
J. Jenner,
C. Dalton,
Robert Chilcott
and
J. S. Graham
Optimisation of mass casualty decontamination procedures in vitro. (2010)
David R. Jones,
Joanne Larner,
Shirley C. Price
and
Robert Chilcott
In vivo decontamination of the nerve agent VX using the domestic swine model. (2012)
Jan Misik,
Michal Pavlik,
Ladislav Novotny,
Ruzena Pavlikova,
Robert Chilcott,
Jiri Cabal
and
Kamil Kuca
Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 2 : Evaluation of in vitro topical decontamination efficacy using undamaged skin. (2015)
Christopher H. Dalton,
Charlotte A. Hall,
Helen L. Lydon,
J. Kevin Chipman,
John S. Graham,
John Jenner
and
Robert Chilcott
Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 1 : Evaluation of in vitro clotting efficacy in the presence of certain contaminants. (2015)
Charlotte A. Hall,
Helen L. Lydon,
Christopher H. Dalton,
J. Kevin Chipman,
John S. Graham
and
Robert Chilcott
Section Editorial - Cosmeceuticals. (2014)
R. P. Chilcott
Section editorial - Regulatory and toxicology. (2014)
R. P. Chilcott
Optimisation of a dosing regime for a topical skin protectant (barrier cream). (2015)
Robert Chilcott,
Joanne Larner,
Hazem Matar,
Sneha Kansagra,
Baveetharan Theivendran,
Vanessa Ann Viegas
and
Virginia Streusand Goldman
Opto-thermal measurement of barrier cream residence time on skin in-vivo. (2001)
X. X. Guo,
L. I. Ciortea,
Robert Chilcott,
R. E. Imhof
and
P. Xiao
Inter- and intralaboratory variation of in vitro diffusion cell measurements : An international multicenter study using quasi-standardized methods and materials. (2005)
Robert Chilcott,
N Barai,
A. E. Beezer,
S I Brain,
Marc Brown,
A L Bunge,
S E Burgess,
S Cross,
C H Dalton,
M Dias,
A Farinha,
B C Finnin,
S J Gallagher,
D M Green,
H Gunt,
R L Gwyther,
C.M. Heard,
C A Jarvis,
F Kamiyama,
G B Kasting,
E E Ley,
S T Lim,
G S Mcnaughton,
A Morris,
M H Nazemi,
M A Pellett,
J Du Plessis,
Y S Quan,
S L Raghavan,
M. Roberts,
W Romonchuk,
C S Roper,
D Schenk,
L Simonsen,
A Simpson,
B D Traversa,
L Trottet,
A Watkinson,
F.M. Williams,
S C Wilkinson,
A Yamamoto
and
J. Hadgraft
Protective effects of clothing on the in vitro absorption of chemical warfare agents. (2010)
Hazem Matar,
Shirley C. Price
and
Robert Chilcott
Design and characterisation of a novel in vitro skin diffusion cell system for assessing mass casualty decontamination systems. (2014)
H. Matar,
J. Larner,
S. Kansagra,
K. L. Atkinson,
J. T. Skamarauskas,
R. Amlot
and
Robert Chilcott
Recent advances to address European Union Health Security from cross border chemical health threats. (2014)
R. Duarte-Davidson,
R. Orford,
S. Wyke,
M. Griffiths,
R. Amlôt
and
Robert Chilcott
Clinical manifestations of VX poisoning following percutaneous exposure in the domestic white pig. (2003)
Robert Chilcott,
C. H. Dalton,
I. Hill,
C. M. Davidson,
K. L. Blohm
and
M. G. Hamilton
Temporal effects of disrobing on the skin absorption of chemical warfare agents and CW agent simulants. (2010)
Hazem Matar,
Shirley C. Price
and
Robert Chilcott
Modified static diffusion cells for decontamination modelling. (2010)
Joanne Larner,
David R. Jones,
Shirley C. Price
and
Robert Chilcott
Evaluation of barrier creams against sulphur mustard: (II) in vivo and in vitro studies using the domestic white pig. (2007)
Robert Chilcott,
Christopher H. Dalton,
Zoe Ashley,
Ceri E. Allen,
Simon T. Bradley,
Michael P. Maidment,
John Jenner,
Roger F. R. Brown,
Robert J. Gwyther
and
Paul Rice
Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro. (2006)
Christopher H. Dalton,
Ian J. Hattersley,
Stephen J. Rutter
and
Robert Chilcott
Closed cup vapor systems in percutaneous exposure studies : What is the dose? (2006)
C. H. Dalton,
Michael P. Maidment,
J. Jenner
and
Robert Chilcott
In vivo skin absorption and distribution of the nerve agent VX (O-ethyl-S-[2(diisopropylamino)ethyl] methylphosphonothioate) in the domestic white pig. (2005)
Robert Chilcott,
C. H. Dalton,
I. Hill,
C. M. Davison,
K. L. Blohm,
E. D. Clarkson
and
M. G. Hamilton
Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig. (2005)
Robert Chilcott,
C. H. Dalton,
I. Hill,
C. M. Davison,
K. L. Blohm,
E. D. Clarkson
and
M. G. Hamilton
Transepidermal water loss does not correlate with skin barrier function in vitro. (2002)
Robert Chilcott,
C. H. Dalton,
A. J. Emmanuel,
C. E. Allen
and
S. T. Bradley
Dermabrasion - a novel concept in the surgical management of sulphur mustard injuries. (2000)
P. Rice,
Roger F. R. Brown,
D. G. K. Lam,
Robert Chilcott
and
N. J. Bennett
Evaluation of barrier creams against sulphur mustard. (2002)
Robert Chilcott,
J. Jenner,
S. A. M. Hotchkiss
and
P. Rice
In vitro skin absorption and decontamination of sulphur mustard : Comparison of human and pig-ear skin. (2001)
Robert Chilcott,
J. Jenner,
S. A. M. Hotchkiss
and
P. Rice
Exposure to UVB radiation does not directly impair skin barrier function. (2001)
C. H. Dalton
and
Robert Chilcott
The electrostability and electrically assisted delivery of an organophosphate pretreatment (physostigmine) across human skin in vitro. (2000)
C. A. Rowland
and
Robert Chilcott
Human skin absorption of bis-2-(chloroethyl)sulphide (sulphur mustard) in vitro. (2000)
Robert Chilcott,
J. Jenner,
W. Carrick,
S. A. M. Hotchkiss
and
P. Rice
Habituating pigs for in-pen, non-invasive biophysical skin analysis. (2001)
Robert Chilcott,
B. Stubbs
and
Z. Ashley
Biophysical measurements of human forearm, skin in vivo : effects of site, gender, chirality and time. (2000)
Robert Chilcott
and
R. Farrar
Non-invasive quantification of skin injury resulting from exposure to sulphur mustard and Lewisite vapours. (2000)
Robert Chilcott,
Roger F. R. Brown
and
P Rice